While HHS Secretary Kennedy frets over food dye in Froot Loops, his 2023 attack on Gardasil — a vaccine proven to prevent ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

One dose of a human papillomavirus (HPV) vaccine was noninferior to two doses in preventing infection, data from a randomized ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results beat estimates. First quarter sales were $15.5 billion, above the $15.3 ...

Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...

A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

Even when equities are volatile, investors can find great stocks to buy. And the rules for investing in the current ...

Find insight on Merck, Sanofi and more in the latest Market Talks covering the Health Care sector.

We preselected all newsletters you had before unsubscribing.

Don't ignore those symptoms. Head and neck cancers are far more manageable, and often curable, with less aggressive treatment ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...